Inventor · disambiguated record
Shripad Bhagwat
Also filed as: BHAGWAT SHRIPAD · Bhagwat Shripad Venkatraman
3 granted patents·8 pending applications·1 citations·filing 2008–2022
54Inventor score
Top patents by PatentIndex Score
11 records- 0176US9526733B1ERK inhibitorsLILLY CO ELI·Filed 2016·Granted Dec 27, 2016·1 cites·8 claims
- 0266US10308608B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted Jun 4, 2019·0 cites·14 claims
- 0364US2021009519A1Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 0459US10851058B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Dec 1, 2020·0 cites·18 claims
- 0554US2022288019A1Methods of treating cancer using a combination of SERD Dosing RegimensLILLY CO ELI·Filed 2022·Application pending·0 cites
- 0648US2022168250A1TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCERLILLY CO ELI·Filed 2020·Application pending·0 cites
- 0747US2023088214A1Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 0844US2009274698A1Combination anti-cancer therapyBHAGWAT SHRIPAD·Filed 2008·Application pending·0 cites
- 0940US2020087314A1Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2017·Application pending·0 cites
- 1035US2020306254A1Combination of erk1/2 inhibitor compound with gemcitabine or with gemcitabine and nab-paclitaxel for use in treatment of pancreatic cancerLILLY CO ELI·Filed 2017·Application pending·0 cites
- 1135US2019151312A1Heparan sulfate biosynthesis inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shripad Bhagwat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →